Atika Capital Management LLC Guardant Health, Inc. Transaction History

Atika Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $3.49 Million - $4.88 Million	80,000 New	80,000 $4.31 Million
Q4 2021 Feb 11, 2022	SELL	$88.71 - $120.43 $7.36 Million - $10 Million	-83,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$98.77 - $132.17 $493,850 - $660,849	-5,000 Reduced 5.68%	83,000 $10.4 Million
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $43,908 - $66,272	400 Added 0.46%	88,000 $10.9 Million
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $940,096 - $1.33 Million	-7,400 Reduced 7.79%	87,600 $13.4 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $1.58 Million - $2.15 Million	15,800 Added 19.95%	95,000 $12.2 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $176,703 - $245,960	2,200 Added 2.86%	79,200 $8.85 Million
Q2 2020 Aug 13, 2020	BUY	$60.49 - $97.5 $4.66 Million - $7.51 Million	77,000 New	77,000 $6.25 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $2.94 Million - $5.18 Million	-47,000 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$63.94 - $91.11 $639,400 - $911,100	-10,000 Reduced 17.54%	47,000 $4.06 Million
Q1 2019 May 13, 2019	BUY	$34.3 - $97.98 $1.96 Million - $5.58 Million	57,000 New	57,000 $4.37 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.